Current Management of Neuroendocrine Tumour Liver Metastases
Open Access
- 13 June 2024
- journal article
- review article
- Published by Springer Nature in Current Oncology Reports
- Vol. 26 (9) , 1070-1084
Abstract
Purpose of review: This article aims to illustrate the current state of investigations and management of liver metastases in patients with Neuroendocrine Neoplasms. Neuroendocrine tumours (NETs) are rising in incidence globally and have become the second most prevalent gastrointestinal malignancy in UK and USA. Frequently, patients have metastatic disease at time of presentation. The liver is the most common site of metastases for gastro-enteropancreatic NETs. Characterisation of liver metastases with imaging is important to ensure disease is not under-staged. Recent Findings: Magnetic resonance imaging and positron emission tomography are now becoming standard of care for imaging liver metastases. There is an increasing armamentarium of therapies available for management of NETs and loco-regional therapy for liver metastases. The data supporting surgical and loco-regional therapy is reviewed with focus on role of liver transplantation. Summary: It is important to use appropriate imaging and classification of NET liver metastases. It is key that decisions regarding approach to treatment is undertaken in a multidisciplinary team and that individualised approaches are considered for management of patients with metastatic NETs.Keywords
This publication has 134 references indexed in Scilit:
- Portal vein embolization versus dual vein embolization for management of the future liver remnant in patients undergoing major hepatectomy: meta-analysisBJS Open, 2022
- Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi‐institutional analysisJournal of Surgical Oncology, 2017
- Outcome after resection and radiofrequency ablation of liver metastases from small intestinal neuroendocrine tumoursBritish Journal of Surgery, 2013
- Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patientsJournal of Surgical Oncology, 2013
- Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structuresJournal of Surgical Oncology, 2012
- Diagnosis of colorectal hepatic metastases: Comparison of contrast‐enhanced CT, contrast‐enhanced US, superparamagnetic iron oxide‐enhanced MRI, and gadoxetic acid‐enhanced MRIJournal of Magnetic Resonance Imaging, 2011
- Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic diseaseBritish Journal of Surgery, 2009
- Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga‐DOTATATE (DOTA‐DPhe1,Tyr3‐octreotate) and 18F‐FDGCancer, 2008
- Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localizationEndocrine-Related Cancer, 2005
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003